143 related articles for article (PubMed ID: 37095029)
21. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
[No Abstract] [Full Text] [Related]
22. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
[No Abstract] [Full Text] [Related]
23. Corrigendum to "7-Deacetyl-gedunin suppresses proliferation of Human rheumatoid arthritis synovial fibroblast through activation of Nrf2/ARE signaling" [Int. Immunopharmacol. 107 (2022) 108557].
Chen J; Zhu G; Sun Y; Wu Y; Wu B; Zheng W; Ma X; Zheng Y
Int Immunopharmacol; 2023 Sep; 122():110702. PubMed ID: 37544812
[No Abstract] [Full Text] [Related]
24. Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2022 Jul; 108():108844. PubMed ID: 35562271
[No Abstract] [Full Text] [Related]
25. Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2020 Sep; 86():106796. PubMed ID: 32674050
[No Abstract] [Full Text] [Related]
26. Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
Gharibi T; Barpour N; Hosseini A; Mohammadzadeh A; Marofi F; Ebrahimi-Kalan A; Nejati-Koshki K; Abdollahpour-Alitappeh M; Safaei S; Baghbani E; Baradaran B
Int Immunopharmacol; 2023 Jun; 119():110303. PubMed ID: 37179201
[No Abstract] [Full Text] [Related]
27. Corrigendum to "Supramolecular salicylic acid ameliorates rosacea-like eruptions by suppressing NLRP3-mediated inflammasome activation in mice" [Int. Immunopharmacol. 118 (2023) 110057].
Wang J; Sun Y; Chen L; Wang Y; Shi D; Wu Y; Gao X
Int Immunopharmacol; 2023 Jun; 119():110233. PubMed ID: 37150709
[No Abstract] [Full Text] [Related]
28. Corrigendum to "Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways". [Int. Immunopharmacol. 66 (2019) 41-51].
Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
Int Immunopharmacol; 2020 Feb; 79():106117. PubMed ID: 31862426
[No Abstract] [Full Text] [Related]
29. Corrigendum to "Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and ameliorates acute lethal sepsis in mice" [Int. Immunopharmacol. 129 (2024) 111615].
Lee DJ; Lee SY; Yi YS
Int Immunopharmacol; 2024 May; 132():111969. PubMed ID: 38575463
[No Abstract] [Full Text] [Related]
30. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
[No Abstract] [Full Text] [Related]
31. Corrigendum to "PAD4 selective inhibitor TDFA protects lipopolysaccharide-induced acute lung injury by modulating nuclear p65 localization in epithelial cells" [Int. Immunopharmacol. 88 (2020) 106923].
Zhao X; Gu C; Wang Y
Int Immunopharmacol; 2023 Dec; 125(Pt B):111185. PubMed ID: 37957096
[No Abstract] [Full Text] [Related]
32. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
Guo R; Li Y; Han M; Liu J; Sun Y
Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
[No Abstract] [Full Text] [Related]
33. Corrigendum to "GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17" [Int. Immunopharmacol. 129 (2024) 111603].
Zhu W; Wang F; Hu C; Zhao Q; Zhang D; Wang X; Hu B; Li J
Int Immunopharmacol; 2024 May; 132():111914. PubMed ID: 38582738
[No Abstract] [Full Text] [Related]
34. Dibenzoylmethane activates Nrf2-dependent detoxification pathway and inhibits benzo(a)pyrene induced DNA adducts in lungs.
Thimmulappa RK; Rangasamy T; Alam J; Biswal S
Med Chem; 2008 Sep; 4(5):473-81. PubMed ID: 18782044
[TBL] [Abstract][Full Text] [Related]
35. Corrigendum to "Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis" [Int. Immunopharmacol. 67 (2019) 129-137].
Zhu L; Gu P; Shen H
Int Immunopharmacol; 2021 Oct; 99():107815. PubMed ID: 34130920
[No Abstract] [Full Text] [Related]
36. Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model.
Yeo CD; Kim JW; Ha JH; Kim SJ; Lee SH; Kim IK; Kim YK
Exp Lung Res; 2014 Dec; 40(10):500-6. PubMed ID: 25275945
[TBL] [Abstract][Full Text] [Related]
37. Corrigendum to "HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils" [Int. Immunopharmacol. 94 (2021) 107433].
Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J
Int Immunopharmacol; 2022 Mar; 104():108461. PubMed ID: 34991980
[No Abstract] [Full Text] [Related]
38. Corrigendum to "HMGB1-TLR4-IL-23-IL-17A axis accelerates renal ischemia-reperfusion injury via the recruitment and migration of neutrophils" [Int. Immunopharmacol. 94 (2021) 107433].
Zhang J; Li Q; Zou YR; Wu SK; Lu XH; Li GS; Wang J
Int Immunopharmacol; 2021 Aug; 97():107573. PubMed ID: 33745852
[No Abstract] [Full Text] [Related]
39. Corrigendum to "Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway" [Int. Immunopharmacol. 56 (2018) 65-70].
Yi L; Lyu YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
Int Immunopharmacol; 2018 Sep; 62():339. PubMed ID: 30007832
[No Abstract] [Full Text] [Related]
40. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
